Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 1997

View Archived Issues

Pharmacia & Upjohn describes HIV reverse transcriptase inhibitors

Japanese scientists report cholecystokinin antagonists

Potent antitumor agents described by Daiichi

Antifungal agent described by Roussel Morishita

New MDR modulators disclosed by Vertex

New antimigraine agent from Pfizer

PDE IV inhibitors revealed by Byk Gulden

New COX-2 inhibitor series reported by Merck Frosst

New PDE IV/TNF inhibitors from Chiroscience

Searle describes antiinflammatory oxazoles

Xoma expands pivotal Neuprex trials

Boston Life Sciences accelerates development of Altropane

AEterna accelerates anticancer clinical program

FDA proposes withdrawal of terfenadine products

Third set of phase III trials on Diatide imaging agent commences

Combination protease inhibitor trial with 141W94/VX-478

FDA clears antimetastatic carbohydrate compound for human trials

Aronex out-licenses antibody-toxin complex

Inhale/Centeon agreement for alpha1-proteinase inhibitor

SyStemix to be integrated into Novartis

Gene Logic/Baylor prostate cancer collaboration

Stanford researchers isolate breast cancer gene

Roche/Genentech marketing agreement for Roferon-A

3DP and ViroPharma establish drug discovery collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...